Docket Number:12A-921104
Inventor:Yijuang Chern
IP Status:Issued TWI328613
Abstract:
Huntington's disease (HD) is an autosomal dominant neurodegenerative disease. We found that over-activation of the AMP-activated kinase (AMPK) exists in the striatum of a transgenic HD mouse model (R6/2). Since AMPK is a master switch for energy metabolism, this observation suggests that energy dysfunctions occurs in HD mice and AMPK inhibitors can be used to treat eurodegenerative disease.
Fields of Application:
Neurodegenerative diseases with dysfunction in energy metabolism
Advantages when compared to the existing technologies:
Overactivation of the AMP-activated kinase (AMPK) is the immediate consequence of energy dysfunction. Treating such deficiency by suppressing the over-expressed AMPK is expected to be effective. To the best of our knowledge, developing neuroprotective strategies targeting on bioenergetic defects for neurodegenerative diseases has not been reported.
Contact Person:Mei-Fang Lee / 886-2-2787-2503 / mflee@gate.sinica.edu.tw
IP Status:Issued TWI328613
